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Abstract
Aims To estimate the incidence of Type 2 diabetes in children aged <17 years, compare this with similar data 10 years
ago, and characterize clinical features at diagnosis in the UK and Republic of Ireland.
Methods Using the British Paediatric Surveillance Unit reporting framework, cases of Type 2 diabetes diagnosed in
children aged <17 years between 1 April 2015 and 30 April 2016 were reported each month.
Results A total of 106 cases were reported, giving a UK incidence of 0.72/100 000 (95% CI 0.58–0.88). Children from
ethnic minorities had significantly higher incidence compared with white children (0.44/100 000) with rates of 2.92/100
000 and 1.67/100 000, in Asian and BACBB (black/African/Caribbean/black British) children respectively. Sixty-seven
percent were girls and 81% had a family history of Type 2 diabetes. The mean BMI SD score at diagnosis was 2.89 (2.88,
girls; 2.92, boys); 81% were obese. Children of Asian ethnicity had a significantly lower BMI SD score compared with
white children (P<0.001). There was a trend in increased incidence from 2005 to 2015, with a rate ratio of 1.35 (95% CI
0.99–1.84), although this was not statistically significant (P=0.062). There was statistical evidence of increased incidence
among girls (P=0.03) and children of South-Asian ethnicity (P=0.01) when comparing the 2005 and 2015 surveys.
Conclusions Type 2 diabetes remains far less common than Type 1 diabetes in childhood in the UK, but the number of
cases continues to rise, with significantly increased incidence among girls and South-Asian children over a decade.
Female gender, family history, non-white ethnicity and obesity were found to be strongly associated with the condition.
Diabet. Med. 35, 737–744 (2018)
Introduction
Type 2 diabetes accounts for 90% of diabetes globally [1]
and prevalence of Type 2 diabetes in adults is increasing in
the UK [2]. The highest rates of Type 2 diabetes in children
and adolescents have been reported in studies from the USA
[3], with the incidence rising from nine to 12.5 cases per 100
000 between 2002 and 2012 [4]. European countries report a
lower incidence, with an Austrian study reporting 0.29 per
100 000 per year between 1999 and 2007 [3]. Recent results
from a multinational European database of >27 000 children
found that Type 2 diabetes accounted for 1.3% of all cases of
diabetes. In Europe, the UK has the highest reported
prevalence of childhood Type 2 diabetes [5]. In 2005, the
UK annual incidence of Type 2 diabetes in children aged <17
years was 0.53 per 100 000 per year [6]. Among children in
the UK, Type 2 diabetes is less common than Type 1
diabetes. The National Paediatric Diabetes Audit 2015–2016
reported that Type 2 diabetes accounted for 2.2% of the
total [7].
Risk factors for developing childhood Type 2 diabetes are
similar to those for adulthood, and include obesity, family
history and ethnicity [8]. A previous UK study reported 95%
of children were overweight or obese at diagnosis [6], with
similar findings from other countries [9]. In the UK,
incidence was substantially higher in ethnic minority groups:
3.9 per 100 000 in BACBB children, and 1.25 per 100 000 in
children of South-Asian ethnicity, compared with 0.35 per
100 000 in white children [6], with similar findings among
non-white ethnicities in other studies [3]. Family history is an
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important risk factor, with 84% reporting a first- or second-
degree relative with Type 2 diabetes [6].
Type 2 diabetes in young people represents an extreme
phenotype of the disease. Young people may present with
complications of diabetes and are more likely to develop
microvascular complications compared with young people
with Type 1 diabetes [8]. The long-term risk of cardiovas-
cular disease in young people diagnosed with Type 2 diabetes
is worse than in those diagnosed later in life [11].
The health, economic and societal impact of early-onset
Type 2 diabetes is concerning. We aimed to estimate the
incidence and to characterize the demographics and presen-
tation of Type 2 diabetes in children aged <17 years in the
UK and Republic of Ireland and to compare these with our
previous study conducted 10 years ago.
Methods
A prospective monthly surveillance of >3400 consultant
paediatricians in the UK and Republic of Ireland using the
British Paediatric Surveillance Unit (BPSU), based at the
Royal College of Paediatrics and Child Health, UK was
undertaken to identify new cases of Type 2 diabetes in
children aged <17 years. The BPSU is an active reporting
system in which an orange report card containing a list of
conditions is sent monthly, by post or electronically, to all
consultant paediatricians. Respondents report cases they
have seen in the previous month for conditions named on the
card or tick ‘Nothing to report’. The BPSU forward the
reporting clinician’s details to the research team, who send a
proforma requesting the child’s clinical details. The study ran
for 13 months (as per previous BPSU studies allowing a lead-
in month) from April 2015 to April 2016.
Diabetes mellitus was defined according to American
Diabetic Association [12] definition with fasting glucose
level >7 mmol/l, random glucose level >11.1 mmol/l or
stimulated glucose level >11.1 mmol/l after a standard oral
glucose tolerance test or HbA1c >48 mmol/mol (6.5%). Type
2 diabetes was distinguished from other types of diabetes
using the following criteria: (1) presence of raised insulin
level (>132 pmol/l) or raised C peptide level (>0.6 nmol/l)
[13,14] or (2) the child was managed off insulin therapy for
>9 months in the absence of typical Type 1 diabetes auto-
antibodies. The latter definition is likely to be based on a
clinical re-evaluation after diagnosis when a clinical course
suggests a diagnosis other than Type 1 diabetes. Exclusion
criteria included: Type 1 diabetes (positive auto-antibodies
and/or persisting insulin requirement from diagnosis); matu-
rity-onset diabetes of the young; diabetes developing in a
person with a known diabetes-associated syndrome, such as
Prader–Willi or Bardet–Biedl syndromes; diagnosis of dia-
betes while on medical therapy with a known diabetogenic
medication and pancreatic failure.
The initial study proforma collected information about the
child, clinical presentation, diagnostic details and manage-
ment. Clinicians were asked to provide evidence of comor-
bidities including hypertension (defined as systolic blood
pressure above the 95th centile for sex, age and height centile
[15]), renal disease (presence of macro/microalbuminuria),
polycystic ovarian syndrome (evidenced by oligo or sec-
ondary amenorrhoea, ultrasonography or a biochemical
picture of luteinizing hormone:follicle-stimulating hormone
ratio >3, low sex hormone binding globulin) and non-
alcholic fatty liver disease (alanine aminotransferase >50 mg/
dl for boys and >44 mg/dl for girls in obese children or
ultrasonography indicating hepatic steatosis with other
aetiologies excluded [16]). A section allowed clinicians to
report other relevant clinical features. A follow-up proforma
was sent 1 year after diagnosis. Case eligibility was deter-
mined on review of the questionnaire by the investigators
(T.C., J.H.S and T.B.).
The methodology was the same used with the BPSU study
in 2004–2005 [6] to allow direct comparison.
Ethics approval
This study was approved by the National Research Ethics
Service Committee South West, Central Bristol, UK [14/SW/
1143] and by the Health Research Authority [15/CAG/
0102].
Statistical analysis
The incidence, defined as number of new cases per popula-
tion over a given period (usually 1 year), was calculated using
valid cases reported between May 2015 and April 2016 (12
consecutive months). The population denominator was
obtained from the ‘Population Estimates Summary for the
What’s new?
• The 2015/2016 UK incidence of Type 2 diabetes in
children aged <17 years was 0.72 per 100 000 per year
• The incidence of Type 2 diabetes amongst girls and
South-Asian children has risen significantly over the last
decade.
• Female gender, family history, non-white ethnicity and
obesity were strongly associated with Type 2 diabetes in
childhood.
• Comorbidities are commonly identified at diagnosis,
including 37% with non-alcoholic fatty liver disease
and 21% with hypertension
• The most common presenting complaint at diagnosis
after osmotic symptoms (polyuria, polydipsia and
weight loss) was recurrent, mainly genital, infections,
although over a third of cases were asymptomatic and
detected on obesity screening investigations
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UK, Mid-2015’ table, published by the Office for National
Statistics (www.ons.gov.uk). Ethnicity-specific incidence
rates were calculated for English and Welsh children only
using the ‘Ethnic Group by Age in England and Wales 2011’
data (www.ons.gov.uk). Data for ethnicity by age were only
available for these two countries. The 95% CIs for incidence
rates were calculated using the exact Poisson method [17].
Poisson regression models were used to compare the
incidences rates in the different ethnic groups. Each ethnic
group was compared with the white ethnicity, baseline
group, and the P values from the Wald test are reported in
Table 1. BMI z-scores (SD scores) at diagnosis were calcu-
lated from weight and height, age and gender using the 1990
UK growth standard curves [18]. For each ethnic group, we
reported the mean difference in BMI SD score from the white
ethnic group, as the baseline group, 95% CI, and the Wald
test P value (Table 2). Overweight and obesity were defined
as described in Cole et al. [19] as follows: SD scores ≥1.30
and ≥2.37, for boys and ≥1.19 and ≥2.25 for girls, respec-
tively. Simple linear regression models were used to compare
the BMI SD scores according to ethnic group. Because the
BMI SD scores are adjusted, by definition, for age and gender,
the resulting estimates consider any potential confounding
effects of these variables when comparing the BMI across the
ethnic groups.
Overall UK incidence, gender-specific and ethnic-specific
incidence rates for 2015 were compared with the corre-
sponding rates for 2005 using incidence rate ratio, defined as
the ratio of incidence in 2015 to 2005 (with null value equal
to 1). P values computed from the z-test for log-ratio of
incidence rates are reported in Table 3. For comparisons of
ethnic group-specific rates, findings were based on the
England figures only, to be comparable with 2005 results.
R Statistical software (version 3.3.2) were used for the
analysis.
The descriptive statistics included all 106 cases (UK and
Republic of Ireland).
Results
A total of 155 case notifications were received during the
13-month study period. The mean monthly BPSU card
return compliance rate was 92%. For the 155 notifications,
148 questionnaires (95%) were received (Fig. 1), 29 cases
were excluded (eight were diagnosed outside the study
period, in seven cases another type of diabetes was
diagnosed, in five cases the individual was aged >17 years
at diagnosis, and nine cases did not meet the criteria for
diabetes or the diabetes was associated with known associ-
ated syndrome/medical treatment, or was made outside the
UK/Republic of Ireland). After case review, 119 cases met
the diagnostic criteria for Type 2 diabetes. Thirteen of these
were excluded, as duplicate cases (two clinicians reporting
cases with the same, unique National Health Service
identification number). A total of 106 cases were identified
as newly confirmed (104 from the UK, two from the
Republic of Ireland).
In all, 67% of cases were in girls (71/106). The median
(range) age at diagnosis was 14.3 (7.9–16.9) years [girls:
14.2 (7.9–16.9) years; boys 14.5 (9.9–16.7) years]. 44% of
the cases the children were white, in 4% of cases the
ethnic group was uncertain and 52% of the cases were in
ethnic minority groups, predominantly Asian/Asian-British
(65%) and BACBB (25%). Of the total cohort, 34% were
Asian or Asian-British (36 cases) and 13% were BACBB
(14 cases).
Table 1 Incidence rates for Type 2 diabetes in children aged 0–16 years in England and Wales, according to ethnic group
Group Ethnicity Population No. cases Incidence rate*† 95% CI
P value
(Wald test)
1 All Ethnicities 11 274 750 88 0.78 0.63–0.96
White: total 8 921 552 39 0.44 0.31–0.60 Baseline group
2 Mixed: total 577 065 <5 0.52 0.11–1.52 0.772
White and black 84 471 <5 2.37 0.29–8.55 0.020
Other mixed 124 917 <5 0.80 0.02–4.46 0.550
3 Asian: total 1 096 304 32 2.92 2.00–4.12 2*10-15
Indian 287 027 <5 1.05 0.22–3.05 0.146
Pakistani 388 889 15 3.86 2.16–6.36 8*10-13
Bangladeshi 163 308 8 4.90 2.11–9.65 5*10-10
Other Asian 201 002 6 2.99 1.10–6.50 1*10-5
4 BACBB: total 537 938 9 1.67 0.77–3.18 3*10-4
Caribbean 111 569 <5 1.79 0.22–6.48 0.052
African 314 374 5 1.59 0.52–3.71 0.007
Other Black 111 996 <5 1.79 0.22–6.45 0.052
5 Other: total 141 891 <5 0.70 0.02–3.93 0.637
Unknown ethnicity <5
*Rates are presented per 100 000/year.
†Poisson regression model was used to compare the incidence rates of the ethnicity groups (labeled 1–5 in the first column). Each ethnic group
and subgroup was compared with group 1, as the baseline group. There was strong evidence that groups 3 (and all its subgroups except those
of Indian origin) and 4 had a higher rate than group 1. For black/African/Caribbean/black British there was evidence of a higher rate than
group 1. Whereas there was no evidence that groups 2 and 5 were differed from 1.
ª 2018 The Authors.
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The mean BMI SD score at diagnosis was 2.89 (girls, 2.88;
boys, 2.92). Of the 106 cases, 102 (96%) were at least
overweight and 81% (86/106) were obese. A total of 2% had
a normal BMI and 2% had no BMI measured. Comparisons
of BMI at diagnosis for each ethnic group are shown in
Fig. 2, and Table 2 shows comparisons of the mean BMI by
ethnicity, compared with white children. Asian children had
a lower BMI at presentation than white children (P <0.001;
Table 2).
A family history of Type 2 diabetes was present in 81% of
cases, with a first-degree relative affected in 70% of cases
(17% both parents affected, 50% mother alone affected,
23% father alone affected, 10% sibling alone affected) and a
second-degree relative in 11%.
In 35% of cases (37/106) the child was asymptomatic at
diagnosis, with diagnosis being made after an incidental
glucose finding or during a clinical assessment for obesity-
related comorbidities. In 53% of cases (56/106), osmotic
symptoms suggestive of diabetes were present (either
polyuria, polydipsia, nocturia or weight loss). Recurrent
infections were reported in 18% of cases (19/106), with
genital/perineal infections being the most common (47%).
Other infections included cellulitis/skin abscesses (26%) and
urinary tract infections (11%). Lethargy was reported in 15%
of the children (16/106). Half of all cases had evidence of
ketonuria at diagnosis. Fewer than five cases presented with
diabetic ketoacidosis or a hyperosmolar hyperglycaemic state.
At diagnosis, non-alcoholic fatty liver disease was reported
in 37%, hypertension in 21%, dyslipidaemia in 9%, renal
disease in 3% and psychological comorbidities in 2% of cases.
A total of 104 newly confirmed cases were from the UK
(excluding two from Republic of Ireland), of which 94 were
diagnosed in the last consecutive 12 months of the study
(May 2015 to April 2016) and were used for calculations of
incidence. The estimated UK population aged <17 years in
mid-2015 was 13 008 432 (www.ons.gov.uk), resulting in a
national UK incidence of Type 2 diabetes in children aged 0–
16 years of 0.72 per 100 000 (95% CI 0.58–0.88). For the
ethnic breakdown of incidence, data from England and
Wales were available. When compared with white children
Table 2 Comparisons of average BMI z-scores for Type 2 diabetes in children aged 0–16 years from different ethnic groups in the UK
Group Ethnicity Mean BMI z-score*† Difference from baseline (95%CI)‡ P value (Wald test)
1 White 3.07 0 Baseline group
2 Mixed 3.50 0.43 (–0.23, 1.10) 0.199
3 Asian§ 2.54 –0.53 (–0.81, –0.24) 4*10-4
4 BACBB 3.08 0.00 (–0.38, 0.39) 0.968
5 Other 2.76 –0.31 (–0.91, 0.30) 0.315
*Linear regression model was used to compare the BMI z-score of the ethnic groups, labelled 1–5 in the first column, with group 1 (those
whose ethnicity was defined as white), as the baseline group.
†The estimated mean of BMI z-score for each ethnic group.
‡The estimated difference (and 95% confidence interval of difference) in means between the corresponding group, reported in the first
column, and the baseline group.
§There were a strong evidence that the Asian group had a lower average of BMI z-scores than the baseline group. It was estimated that a child
with Type 2 diabetes whose ethnic group defined as ‘Asian‘ had, on average, 0.53 (95% CI 0.24–0.81) lower BMI z-score than a white child
with Type 2 diabetes. There was no evidence that other groups were differed from the baseline group.
Table 3 Comparisons between 2005 and 2015 UK incidence rates for Type 2 diabetes in children aged 0–16 years for whole population and for
populations classified by gender and ethnicity
2005 2015 Ratio of 2015/2005
Population No. of cases IR* 95% CI Population
No. of
cases IR 95% CI IRR 95% CI
P value
(Z-test)§
Total 12 495 153 67 0.53 0.41–0.68 13 008 432 94 0.72 0.58–0.88 1.35 0.99–1.84 0.062
Gender
Females 6 098 516 38 0.62 0.44–0.86 6 345 915 62 0.98 0.75–1.25 1.57 1.05–2.35 0.029
Males 6 396 637 29 0.45 0.30–0.65 6 662 517 32 0.48 0.33–0.68 1.06 0.64–1.75 0.822
Ethnicity†
White 10 857 143 38 0.35 0.20–0.50 8 366 173 36 0.43 0.30–0.60 1.23 0.78–1.94 0.374
BACBB 333 333 13 3.90 2.10–6.70 533 457 9 1.69 0.77–3.20 0.43 0.18–1.01 0.053
South Asians‡ 800 000 10 1.25 0.60–2.40 827 786 26 3.14 2.05–4.60 2.51 1.21–5.21 0.013
IR, incidence rate; IRR, incidence rate ratio (2015 rate/2005 rate).
*Rates are presented per 100 000/year. †Ethnicity comparisons were based on England figures only to be comparable with 2005 findings.
Rates are presented per 100 000/year.
‡South-Asian ethnicity includes only the Indian, Pakistani and Bangladeshi ethnic groups to follow those of the 2005 study methodology.
§P values were computed by using the Z-test with the log-ratio of the incidence rates.
740
ª 2018 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
DIABETICMedicine Incidence of Type 2 diabetes in children  T. P. Candler et al.
FIGURE 1 Flowchart of cases’ classification. D, Duplicate report; DP, Duplicate positive (i.e. duplicate of confirmed case); IRE, Republic of Ireland;
NP, No response received
FIGURE 2 Box-plots for the BMI z-scores (SD scores) of children aged 0–16 years in UK, grouped by their ethnicity
ª 2018 The Authors.
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[0.44 per 100 000 (95% CI 0.31–0.60)], there was strong
evidence that Asian [2.92 per 100 000 (95% CI 2.00–4.12);
P <0.001] and BACBB children [1.67 per 100 000 (95% CI
0.77–3.18); P <0.001] children had a higher incidence of
Type 2 diabetes (Table 1).
Comparing 2005 with 2015 data, there was a trend
towards increased incidence of Type 2 diabetes (incidence
rate ratio 1.35, 95% CI 0.99–1.84), although this was not
statistically significant (P=0.062; Table 3). There was statis-
tical evidence that the incidence had increased among girls
(P=0.03) and South-Asian children (P=0.01) over the decade
(Table 3).
Discussion
In the UK, the incidence of Type 2 diabetes among girls and
South-Asian children is increasing. The first study to quantify
accurately the incidence in the UK was in 2005 [6], using a
similar methodology to that used in the present study and
thereby allowing comparison a decade later. Sixty-seven
cases were reported in 2004–2005, while the present study
identified 106 cases, with incidence rising from 0.53 per 100
000 (95% CI 0.41–0.68) in 2004–2005 to 0.72 per 100 000
(95% CI 0.58–0.88). The incidence in white children in
2004–2005 was 0.35 per 100 000 (95% CI 0.2–0.5) and in
2015–2016 it was 0.43 per 100 000 (95% CI 0.30–0.58),
demonstrating a modest increase. Generally, the higher
national incidence is a result of significantly higher rates
among ethnic minorities, despite Asian and BACBB children
accounting for 9.7% and 4.8% of the population in England
and Wales respectively. Compared with white children,
Asian children had an incidence nearly seven times and
BACBB children nearly four times greater. The rise in cases
among Asian children means that they represent a higher
proportion of cases compared with BACBB children, while
previously the reverse was described [6]. Previous estimates
of the prevalence of Type 2 diabetes among young people of
Asian ethnicity may be underestimates because a proportion
were initially misdiagnosed as having Type 1 diabetes [20].
The UK incidence is still lower than in the USA [4], Japan
and Taiwan [3] but higher than in previous studies from
Europe [3]. The higher incidence in ethnic minority groups
has been described in many previous studies [4]. It is notable
that only one case in 2005 and two cases from 2015 were
reported from the Republic of Ireland. It could be speculated
that this relates to the less diverse ethnic background of the
citizens in that country.
A major driver of the development of Type 2 diabetes is
obesity. Most children in our cohort were overweight or
obese. With 53% of the cases presenting with osmotic
symptoms including weight loss, the BMI recorded at
diagnosis may be lower than earlier in the disease process.
Asian children present with Type 2 diabetes at a significantly
lower BMI than do white children, which has been described
previously [21] and may be related to ethnic differences in
visceral fat distribution which corresponds to increased
metabolic risk. Obesity prevalence in the UK has increased
dramatically over the last 20 years. Childhood obesity
increased between 1994 and 2003, although the overall
trend stabilized between 2004 and 2013. In the 11–14-year
age group, however, there was a continued trend in increased
obesity albeit at a slower rate than the previous decade [22].
The increased incidence of Type 2 diabetes may not be solely
explained by rising obesity rates but may also be attributable
to greater awareness of the disease in the paediatric popu-
lation, changing demographics in the UK and better screen-
ing for comorbidities related to obesity.
Family history of Type 2 diabetes clearly plays a role in
developing the condition in childhood. The interplay
between genetic predisposition and obesogenic environment
(which families often share) can be difficult to characterize.
Impaired glucose handling is seen more frequently in non-
obese children with a family history of Type 2 diabetes than
in those with no family history [23], suggesting the impor-
tance of genetic predisposition. Two-thirds of the cases were
female, significantly higher than in 2005 [6]. This female
preponderance has been described previously [10] and the
UK National Paediatric Diabetes Audit reported a female:
male ratio of ~2:1 [7]. Girls tend to reach puberty earlier and
puberty is associated with fat accumulation. This may
contribute to greater insulin resistance in girls than in boys
of a similar age. Physical activity levels also tend to be lower
among adolescent girls than boys [24] and this may be
detrimental to metabolic health.
The present study suggests the importance of screening for
Type 2 diabetes in obese individuals, as 35% of our cases
were asymptomatic at diagnosis. UK national guidelines
recommend assessment (including consideration of measure-
ment of fasting glucose and insulin, HbA1c and an oral glucose
tolerance test) of comorbidities related to obesity, including
diabetes in those above the 98th centile for BMI [25].
Recurrent infections, especially those affecting the genitalia,
were the most common presentation after osmotic symp-
toms. We advocate screening for Type 2 diabetes in
overweight children presenting with recurrent perineal or
cutaneous infections. Ketoacidosis is a rare presentation in
Type 2 diabetes but does occur, as evidenced by cases in our
cohort.
Non-alcoholic fatty liver disease was the most commonly
reported comorbidity (37%) and has previously been
reported in approximately half of adolescents with Type 2
diabetes [26]. A recent study in children and adolescents
with non-alcoholic fatty liver disease reported a prevalence
of impaired glucose tolerance of 23.4% and of Type 2
diabetes of 6.5% [27]. Our finding of hypertension in 21%
of children at diagnosis is consistent with other studies,
which have reported rates of hypertension in adolescents of
10–55% at diagnosis [28,29], although it was lower than the
34% rate reported in the 2005 cohort [30]. In 11 cases no
blood pressure data were available, therefore, cases of
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hypertension may have been missed. Our observation of renal
disease in 3% of cases is low compared with previous studies
[29], which have reported rates of 7–22% of microalbumin-
uria at diagnosis in adolescents. This relatively small number
of cases with renal disease is similar to the number observed
in the 2005 cohort, in which early nephropathy was rare
(4%) [30]. This may reflect either a lack of screening for renal
disease by clinicians, as 32% of cases did not report data on
albuminuria, earlier diagnosis of diabetes, or a lower
incidence of microalbuminuria. Certainly, as the rate of
progression of microalbuminuria and renal disease is rapid in
adolescents with Type 2 diabetes, with 28% prevalence of
microalbuminuria reported at 1.3 years after diagnosis [29],
careful screening and monitoring is crucial. Follow-up data
on this cohort will give valuable insights into any progression
and change in prevalence of nephropathy.
Surveys relying on clinicians reporting data have the
potential to underestimate the true incidence of a disease.
Clinical information was available from 95% of notifica-
tions, thus there was only a small proportion (5%) of missing
data resulting from incomplete reporting. Over the study
period, there was a mean monthly orange card return of
92%, leaving potential for cases not being reported. There
was a mean monthly case notification card return of 93% in
the study in 2005 [6]; therefore, the potential for error was
similar in the two studies. It is recommended that children
with diabetes are managed in secondary care, however, it is
possible that some young people, especially those aged 16–17
years, with Type 2 diabetes are managed in primary care.
These cases would not be detected by the BPSU reporting
system.
Our data suggest the number of cases of childhood Type 2
diabetes is rising in the UK, although Type 2 diabetes in
children is still unusual compared Type 1 diabetes [7].
Female gender, non-white ethnicity and a family history of
Type 2 diabetes were strongly associated with the disease.
Follow-up data from the present cohort will characterize the
management, clinical course and development of comorbidi-
ties in this population. Further work is needed to prevent the
development of Type 2 diabetes and to understand the
processes leading to Type 2 diabetes developing amongst
children with obesity. The long-term health and economic
implications of the rising incidence in the UK will become
evident in the coming decades, although this should be of
great concern to clinicians and policy makers.
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